Mild persistent asthma, uncomplicated
ICD-10 J45.30 is a billable code used to indicate a diagnosis of mild persistent asthma, uncomplicated.
Mild persistent asthma, uncomplicated, is characterized by symptoms occurring more than twice a week but less than once a day. Patients may experience nighttime symptoms more than twice a month, and their lung function is typically normal between exacerbations. The respiratory system, particularly the bronchi and bronchioles, is primarily affected, leading to inflammation, bronchoconstriction, and increased mucus production. This condition can progress if not managed properly, potentially leading to more severe asthma forms. Diagnostic considerations include a thorough patient history, physical examination, and spirometry to assess lung function. Peak flow monitoring may also be utilized to evaluate the severity of asthma and guide treatment decisions. Patients often respond well to inhaled corticosteroids and bronchodilators, which help control symptoms and prevent exacerbations. Regular follow-ups are essential to monitor the condition and adjust treatment as necessary.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J45.30 specifically covers mild persistent asthma, which includes patients experiencing symptoms more than twice a week but less than daily, with nighttime symptoms occurring more than twice a month. It does not include patients with more severe forms of asthma or those with complications.
J45.30 should be used when a patient has mild persistent asthma without complications. It is important to differentiate it from J45.20 (mild intermittent asthma) and J45.31 (moderate persistent asthma) based on the frequency and severity of symptoms.
Documentation should include a detailed history of asthma symptoms, frequency of exacerbations, response to treatment, and results from lung function tests such as spirometry. Regular follow-up notes should also be included to demonstrate ongoing management.
